FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

NCT05077800 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma
Pancreatic Adenocarcinoma Metastatic

Interventions

DRUG: FOLFIRNINOX
DRUG: Losartan
DRUG: 9-ING-41

Sponsor

Colin D. Weekes, M.D., PhD

Collaborators

[object Object]
[object Object]